New biothreat of JN.1 variant SARS CoV-2: viral genome, mutations and comparison with Delta and Omicron variants – a brief commentary
SARS-CoV-2, the etiologic agent of COVID-19, is susceptible to mutations and emerged into many variants. This study aims to investigate a new variant called JN.1 with a remarkable number of mutations reported from many countries. All viral members of Coronaviridae are single-stranded RNA viruses. I...
Saved in:
| Main Authors: | S. Kannan, U. Zeba, F. Razana, A. Huda, L. Punya, A. Sheeza, S. Salajegheh Tazerji, P. Magalhães Duarte |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Verduci Editore
2024-03-01
|
| Series: | Infectious Diseases and Tropical Medicine |
| Subjects: | |
| Online Access: | https://www.infectiousjournal.com/wp-content/uploads/sites/6/2024/03/e1374.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An mRNA vaccine encoding the SARS-CoV-2 Omicron XBB.1.5 receptor-binding domain protects mice from the JN.1 variantResearch in context
by: Ryuta Uraki, et al.
Published: (2025-07-01) -
Clinical Characteristics and Outcomes of Hospitalized COVID-19 Patients with Different Variants of SARS-CoV-2 in a Tertiary Care Hospital, Thailand
by: Kitchawan Hengkrawit, et al.
Published: (2024-11-01) -
Experimental co-infection of calves with SARS-CoV-2 Delta and Omicron variants of concern
by: Konner Cool, et al.
Published: (2024-12-01) -
A comparative analysis exposes an amplification delay distinctive to SARS-CoV-2 Omicron variants of clinical and public health relevance
by: K.L. Brown, et al.
Published: (2023-12-01) -
Fortifying defenses: Tactical safety protocols for COVID-19 sub-variant JN.1 in healthcare and laboratory settings
by: Shazima Sheereen, et al.
Published: (2025-01-01)